Italy Pharmaceuticals and Healthcare Report Q4 2008

  • ID: 680273
  • December 2008
  • Region: Italy
  • 65 Pages
  • Business Monitor International
1 of 4


  • GlaxoSmithKline
  • Merck & Co
  • Novartis
  • Pfizer
  • Recordati
  • Sanofi-Aventis
  • MORE

Our Italy Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Italy's pharmaceuticals and healthcare industry.

The poor performance in the Italian market looks set to continue over the forecast period. Following low growth in 2005 and 2006, the market posted a decline in 2007. Between 2007 and 2012 the compound annual growth rate (CAGR) should be just 1.85% in local currency terms, with the market reaching a value of EUR25.1bn (US$US$32.2bn). The first six months of 2008 seem to support this pessimistic prognosis, with market expenditure by the Italian National Health Service - the Servicio Sanitario Nazionale (SSN) - falling by 1.4% (year-on-year).

From 2006, the state has made a concerted effort to decrease prices through initiatives including increasing generic penetration, the introduction of new reference pricing and across-the-board price cuts. This had a significant impact on spending in 2007, the effects of which are being carried through into2008 with average price reductions of 6.9% y-o-y per pack in the first half.

As a result, most of Italy’s major pharmaceutical players have been looking to foreign READ MORE >

Note: Product cover images may vary from those shown
2 of 4


  • GlaxoSmithKline
  • Merck & Co
  • Novartis
  • Pfizer
  • Recordati
  • Sanofi-Aventis
  • MORE

Executive Summary
Table: Italy Pharmaceuticals And Healthcare Industry SWOT
Italy Political SWOT
Italy Economic SWOT
Pharmaceutical Business Environment Ratings
Table: Western Europe Pharmaceutical Business Environment Rankings
Limits Of Potential Returns
Risks To Realisation Of Returns
Market Summary
Healthcare Sector
Regulatory Regime
Intellectual Property Developments
Industry Developments
Company Developments
Foreign Markets Aid Recordati In 2008
Clinical Trials
Wholesale and Pharmacy Sectors
Table: Disease Burden In Western Europe
Industry Forecast Scenario
Overall Market Forecast
Table: Drug Market Indicators
Key Growth Factors – Industry
Table: Health Expenditure Indicators
Key Growth Factors – Macroeconomic
Table: Italy - Macroeconomic Forecasts
Prescription Market Forecast
Table: Prescription Market Indicators
OTC Market Forecast
Table: OTC Market Indicators (US$mn unless otherwise stated)
Generics Market Forecast
Table: Generics Market Indicators
External Trade Forecast
Table: Pharmaceutical Trade Indicators (US$mn)
Medical Devices
Table: Italy’s Medical Device Market, 2006-2012 (US$bn unless otherwise stated)
Other Healthcare Data Forecasts
Table: Italian Socio-Demographic Indicators
Competitive Landscape
Company Profiles
Leading Multinational Manufacturers
Merck & Co
Indigenous Manufacturer
Country Snapshot: Italy Demographic Data
Section 1: Population
Table: Demographic Indicators, 2005-2030
Table: Rural/Urban Breakdown, 2005-2030
Section 2: Education And Healthcare
Table: Education, 2002-2005
Table: Vital Statistics, 2005-2030
Section 3: Labour Market And Spending Power
Table: Employment Indicators, 2001-2006
Table: Consumer Expenditure, 2000-2012 (US$)
Table: Average Annual Manufacturing Wages, 2000-2012
Our Forecast Modelling
How We Generate Our Pharmaceutical Industry Forecasts
Pharmaceutical Business Environment Ratings Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Table: Weighting Of Components

Note: Product cover images may vary from those shown
3 of 4

- GlaxoSmithKline
- Merck & Co
- Novartis
- Pfizer
- Recordati
- Sanofi-Aventis

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown


  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.


If you have a more general question about our products please try our



Our Clients

  • AB Sciex
  • Eli Lilly and Company
  • B. Braun Melsungen AG
  • Astellas Pharma, Inc.
  • Hologic Inc.
  • Merck & Co., Inc.